Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 8 December 2009
[DOI: 10.1126/scisignal.2000643]

Supplementary Materials for:

Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction

Andrea Bertotti, Mike F. Burbridge, Stefania Gastaldi, Francesco Galimi, Davide Torti, Enzo Medico, Silvia Giordano, Simona Corso, Gaëlle Rolland-Valognes, Brian P. Lockhart, John A. Hickman, Paolo M. Comoglio,* Livio Trusolino*

*To whom correspondence should be addressed. E-mail: livio.trusolino{at}ircc.it (L.T.) and paolo.comoglio{at}ircc.it (P.M.C.)

This PDF file includes:

  • Fig. S1. Validation of phosphoprotein antibodies for multiplex phosphoproteomic analysis.
  • Fig. S2. Met inhibition has little or no effects on the activation of p38 MAPK, JNK, STAT3, and NF-κB.
  • Fig. S3. Met inhibition neutralizes the activity of AKT and ERK1/2.
  • Fig. S4. Microarray validation by TaqMan low-density quantitative PCR arrays.
  • Fig. S5. Effects of MEK, PI3K, and AKT inhibitors on downstream effectors in GTL16 cells.
  • Fig. S6. Basal proliferation curves of PHA-resistant GTL16 cells.

[Download PDF]

Technical Details

Format: Adobe Acrobat PDF

Size: 2.5 MB

Other Supplementary Material for this manuscript includes the following:

  • Table S1. Phosphoproteomic analysis of cell lines treated with PHA or gefitinib.
  • Table S2. Transcriptional profiles of GTL16 and DiFi cells treated with PHA or gefitinib.
  • Table S3. Functional annotation analysis of genes significantly downregulated by PHA in GTL16 cells.
  • Table S4. Gene set enrichment analysis (GSEA) results for Genesets downregulated by PHA in GTL16 cells.
  • Table S5. TaqMan validation of the transcriptional response to Met inhibition in Met-amplified cell lines.
  • Table S6. Transcriptional profiles of control GTL16 (mock), GTL16 expressing B-RAFV600E and AKTMyr, and GTL16 expressing K-RASG12V treated with PHA.
  • Table S7. Mutational analysis of Met- and EGFR-addicted cell lines.
[Download Tables S1 to S7 (Compressed)]

Technical Details

Format: Microsoft Excel

Size: 1.25 MB (compressed); 5.21 MB (decompressed)


For files packaged as a compressed archive, in *.zip format; users should download the compressed file to their machine and decompress the file on their local hard drive, using the following instructions.

Instructions for downloading and decompressing files:

1. Create a temporary folder on your machine's hard drive.

2. Save the compressed archive to the temporary folder you created, using the links above.

3. Decompress the compressed file in the temporary folder using decompression software, such as WinZip (Windows; www.winzip.com) or StuffIt Expander (Windows and Mac; www.stuffit.com).

Excel files can be opened and viewed using Microsoft Excel, the spreadsheet module of the freely downloadable Open Office suite, or the freely downloadable Excel Viewer available from Microsoft.


Citation: A. Bertotti, M. F. Burbridge, S. Gastaldi, F. Galimi, D. Torti, E. Medico, S. Giordano, S. Corso, G. Rolland-Valognes, B. P. Lockhart, J. A. Hickman, P. M. Comoglio, L. Trusolino, Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction. Sci. Signal. 2, ra80 (2009).

© 2009 American Association for the Advancement of Science


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882